Hot of the Press August 2021
We have collated some great articles and material published over the last month. Click on the links below to read the abstract or download the full paper.
Anatomy / Physiology /Pathophysiology
Pathophysiology of the Lymphatic System in Patients With Heart Failure: JACC State-of-the-Art Review - click for abstract
The removal of interstitial fluid from the tissues is performed exclusively by the lymphatic system. Tissue edema in congestive heart failure occurs only when the lymphatic system fails or is overrun by fluid leaving the vascular space across the wall of the capillaries into the interstitial space. This process is driven by Starling forces determined by hydrostatic and osmotic pressures and organ-specific capillary permeabilities to proteins of different sizes. In this review, we summarize current knowledge of the generation of lymph in different organs, the mechanics by which lymph is returned to the circulation, and the consequences of the inadequacy of lymph flow. We review recent advances in imaging techniques that have allowed for new research, diagnostic, and therapeutic approaches to the lymphatic system. Finally, we review how efforts to increase lymph flow have demonstrated potential as a viable therapeutic approach for refractory heart failure.
Cellulitis Is Associated with Severe Breast Cancer-Related Lymphedema: An Observational Study of Tissue Composition - click for abstract
Cellulitis Is Associated with Severe Breast Cancer-Related Lymphedema: An Observational Study of Tissue Composition
The effects of lower body compression on left ventricular rotational mechanics in lymphoedema (from the MAGYAR-Path Study) - click for abstract
The effects of lower body compression on left ventricular rotational mechanics in lymphoedema (from the MAGYAR-Path Study)
Vascular and lymphatic abnormalities - click for abstract
Vascular and lymphatic abnormalities
Prevalence and Risk Factors
Breast cancer-related lymphedema and its treatment: how big is the financial impact? - click for abstract
Breast cancer-related lymphedema and its treatment: how big is the financial impact?
Tessa De Vrieze1,2 & Nick Gebruers 2,3 & Ines Nevelsteen4 & Wiebren A. A. Tjalma3,5 & Sarah Thomis6 &
An De Groef1,2 & Lore Dams1,2 & Vincent Haenen1,2 & Nele Devoogdt1,6. Supportive Care in Cancer (2021) 29:3801–3813.
Purpose Decongestive lymphatic treatment (DLT) is still the gold standard for treatment of breast cancer-related lymphedema (BCRL). With up to 17% of the patients treated for breast cancer developing BCRL, this morbidity imposes a tremendous financial burden for patients and society. Knowledge about this economic burden related to BCRL and its conservative treatment in a European setting is lacking. The aim of this prospective, longitudinal cohort study was to estimate the direct healthcare costs related to BCRL and its treatment in a European setting.
Methods Patients with BCRL were treated with DLT consisting of an intensive treatment phase of 3 weeks, followed by a maintenance treatment phase of 6 months. Additionally, the follow-up period comprised 6 months. During these 3 weeks and 12 months, all direct costs associated with the treatment of BCRL and its sequelae were documented through billing prices and a self-developed questionnaire which was administered after the intensive treatment phase, and subsequently 3-monthly during the entire period.
Results A total of 194 patients were enrolled in this study. Of these, 17% (n = 32) showed lymphedema stage I, 56% (n = 109) had lymphedema stage IIa, and 27% (n = 53) had lymphedema stage IIb. Total direct healthcare costs per patient were €2248.93 on average during the entire period of 3 weeks of intensive treatments and 12 months of maintenance decongestive therapy. Within these mean direct costs, €1803.35 (80%) was accounted for statutory health insurances, and €445.58 (20%) was out-of-pocket expenses for patients.
Conclusion This study is one of the first standardized high-quality health economic analyses of BRCL treatment in Europe. The present study indicates that the price tag of BCRL treatment in Belgium is high not only for the health insurance but also for the patients.
Drug-induced peripheral oedema: An aetiology-based review - click for abstract
Drug-induced peripheral oedema: An aetiology-based review
Bérenger Largeau1, Jean-Luc Cracowski2, Céline Lengellé1, Bénédicte Sautenet3,4, Annie-Pierre Jonville-Béra1, Br J Clin Pharmacol. 2021;87:3043–3055.
Many drugs are responsible, through different mechanisms, for peripheral oedema. Severity is highly variable, ranging from slight oedema of the lower limbs to anasarca pictures as in the capillary leak syndrome. Although most often noninflammatory and bilateral, some drugs are associated with peripheral oedema that is readily erythematous (eg, pemetrexed) or unilateral (eg, sirolimus). Thus, drug-induced peripheral oedema is underrecognized and misdiagnosed, frequently leading to a prescribing cascade. Four main mechanisms are involved, namely precapillary arteriolar vasodilation (vasodilatory oedema), sodium/water retention (renal oedema), lymphatic insufficiency (lymphedema) and increased capillary permeability (permeability oedema). The
underlying mechanism has significant impact on treatment efficacy. The purpose of this review is to provide a comprehensive analysis of the main causative drugs by illustrating each pathophysiological mechanism and their management through an example of a drug.
Early side effects of radiation treatment for head and neck cancer - click for abstract
Early side effects of radiation treatment for head and neck cancer
I. Brook. Cancer/Radiothérapie 25 (2021) 507–513
Purpose of this review of medical literature is to present the immediate side effects of radiation therapy for head and neck cancer and their treatment. The likelihood and severity of these immediate side effects depends on a number of factors, including the total dose of radiation delivered, over what time it was delivered and what parts of the head and neck received radiation. Early side effects include: inflammation of the oropharyngeal mucosa (mucositis), painful swallowing (odynophagia), difficulty swallowing (dysphagia), hoarseness, lack of saliva (xerostomia), orofacial pain, laryngeal radionecrosis, dermatitis, hair loss, nausea, vomiting, inadequate nutrition and hydration, and weight loss. These complications can interfere with, and delay treatment. Most of these side effects generally dissipate over time. In conclusion, radiation treatment for the head and neck cancer causes significant early side effects. Many of these side effects present difficult challenges to the patients. Their recognition and treatment can significantly improve the patients’ health, long-term survival and quality of life. The review provides information that can assist head and cancer survivors deal with radiation side effects.
Influence of age and lymphedema on the postural balance of women undergoing breast cancer treatment - click for abstract
Influence of age and lymphedema on the postural balance of women undergoing breast cancer treatment
Cristina Faustino Cuviena , Carla Silva Perez , Victoria Carrer Nardo , Lais Mara Siqueira das Neves , Flavia Belavenuto Rangon , Elaine Caldeira de Oliveira Guirro *.Journal of Bodywork & Movement Therapies 27 (2021) 307e313.
Introduction: Breast cancer affects women of different ages, and comorbidities resulting from treatment can affect postural stability. The study aimed to evaluate the influence of age and lymphedema on the postural balance of women undergoing breast cancer treatment.
Methods: The study included 77 women undergoing breast cancer treatment, divided into different groups: 37 young adult women divided into 17 with lymphedema (GYL) and 20 young adults without lymphedema (GY); 40 elderly women, 20 elderly women with lymphedema (GEL) and 20 elderly women without lymphedema (GE). Mini Balance Evaluation Systems Test (Mini BESTest) and Falls Efficacy Scale – International (FES-I) were used.
Results: Mini BESTest and FES-I between the groups showed that GE and GEL had a significant difference to GY. Mini BESTest Total and Time Up and Go TUG-Double Task showed that GE has a significant difference to GYL, with GE and GEL having lower scores. Moderate negative correlation in the GEL between FES-I and Mini BESTest. In the age correlation between the Mini BESTest, FES-I, TUG, and double task TUG, a moderate positive correlation was observed for TUG. GEL showed a moderate positive correlation for FES-I and double-task TUG, strong for TUG, and moderate negative correlation with Mini BESTest. Correlation of the volume difference between the limb affected and not affected by lymphedema and the FES-I, Mini BESTest, TUG, and TUG double task, GYL showed moderate negative correlation for TUG.
Conclusion: Age and lymphedema influenced the dynamic postural balance of women undergoing breast cancer treatment
The Effects of Obesity on Lymphatic Pain and Swelling in Breast Cancer Patients - click for abstract
The Effects of Obesity on Lymphatic Pain and Swelling in Breast Cancer Patients
Mei Rosemary Fu 1,† , Deborah Axelrod 2,†, Amber Guth 2, Melissa L. McTernan 3, Jeanna M. Qiu 4, Zhuzhu Zhou 3, Eunjung Ko 5, Cherlie Magny-Normilus 6, Joan Scagliola 7 and Yao Wang 8. Biomedicines 2021, 9, 818.
Background: Lymphatic pain and swelling due to lymph fluid accumulation are the most common and debilitating long-term adverse effects of cancer treatment. This study aimed to quantify the effects of obesity on lymphatic pain, arm, and truncal swelling.
Methods: A sample of 554 breast cancer patients were enrolled in the study. Body mass index (BMI), body fat
percentage, and body fat mass were measured using a bioimpedance device. Obesity was defined as a BMI ≥ 30 kg/m2. The Breast Cancer and Lymphedema Symptom Experience Index was used to measure lymphatic pain, arm, and truncal swelling. Multivariable logistic regression models were used to estimate the odds ratio (OR) with 95% confidence interval (CI) to quantify the effects of obesity.
Results: Controlling for clinical and demographic characteristics as well as body fat percentage, obesity had the greatest effects on lymphatic pain (OR 3.49, 95% CI 1.87–6.50; p < 0.001) and arm swelling (OR 3.98, 95% CI 1.82–4.43; p < 0.001). Conclusions: Obesity is a significant risk factor for lymphatic pain and arm swelling in breast cancer patients. Obesity, lymphatic pain, and swelling are inflammatory conditions. Future study should explore the inflammatory pathways and understand the molecular mechanisms to find a cure.
Assessment
Accuracy, Sensitivity, and Specificity of the LLIS and ULL27 in Detecting Breast Cancer-Related Lymphedema - click for abstract
Accuracy, Sensitivity, and Specificity of the LLIS and ULL27 in Detecting Breast Cancer-Related Lymphedema
Lived Experiences for Supportive Care Needs of Women with Breast Cancer-Related Lymphedema: A Phenomenological Study - click for abstract
Assessment of local tissue water in breasts following breast reconstruction with an expander prosthesis or DIEP flap
Management Strategies
Exercising and Compression Mechanism in the Treatment of Lymphedema - click for abstract
Exercising and Compression Mechanism in the Treatment of Lymphedema
American Society of Breast Surgeons’ Practice Patterns for Patients at Risk and Affected by Breast Cancer-Related Lymphedema - click for abstract
Hemodynamic Responses in Lower Limb Lymphedema Patients Undergoing Physical Therapy - click for abstract
heart rate during orthostatic loading over all epochs on therapy day 14, as well as day 21. Volume regulatory hormones did not show changes over lymphedema therapy.
Treatment of Breast Cancer−Related Lymphedema Using Negative Pressure Massage: A Pilot Randomized Controlled Trial - click for abstract
Physical activity level, exercise behavior, barriers, and preferences of patients with breast cancer–related lymphedema - click for abstract